march 21 reuter us lawmak ask brief gilead scienc inc price new hepat c drug sovaldi
letter gilead democrat hous energi commerc committe ask inform sovaldi discount payor patient
recent approv medicin seen breakthrough treatment seriou liver diseas cost 8400 per patient
gilead share 4 percent morn trade nasdaq
